The Fungal PCR Initiative's evaluation of in-house and commercial Pneumocystis jirovecii qPCR assays: Toward a standard for a diagnostics assayMaud Gits‐Muselli, Alexandre Alanio, P. Lewis White et al.|Medical Mycology|2019Cited by 74
Detailed characterization of the first high-level azithromycin-resistant <i>Neisseria gonorrhoeae</i> cases in IrelandYvonne Lynagh, Brendan Crowley, Micheál Mac Aogáin et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 26
Identification of emergent blaCMY-2-carrying Proteus mirabilis lineages by whole-genome sequencingMicheál Mac Aogáin, Brendan Crowley, Thomas R. Rogers|New Microbes and New Infections|2015Cited by 22
Fourteen Draft Genome Sequences for the First Reported Cases of Azithromycin-Resistant Neisseria gonorrhoeae in IrelandMicheál Mac Aogáin, Brendan Crowley, Brendan Lawlor et al.|Genome Announcements|2017Cited by 6
Comment on: T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot studyP Lewis White, Volker Rickerts, Rosemary A. Barnes et al.|Journal of Antimicrobial Chemotherapy|2018Cited by 4